Protara Therapeutics, Inc.
TARA$112M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaNEW YORK28 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Aug 10, 2026
7wMarket Overview
Stock performance and key metrics
TARA News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Choline Chloride for Injection
Choline Deficiency
TARA-002
Non-muscle Invasive Bladder Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Choline Chloride for Injection | Phase 3 | Choline Deficiency | - | - |
TARA-002 | Phase 2 | Non-muscle Invasive Bladder Cancer | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply